Increased Risk for Venous Thromboembolism in Patients Receiving Anticoagulant Therapy for Pulmonary Embolism
Researchers assessed incidence of recurrent thromboembolism and major bleeding in patients with cancer and incidental pulmonary embolism.
Pulmonary Embolism
Risk Factors for Recurrent Venous Thromboembolism in Patients With Sickle Cell Disease
Patients with severe sickle cell disease were more than twice as likely to experience recurrent thromboembolism compared with patients with less severe disease.
VTE-BLEED Risk Score Reliably Identifies Patients With PE at Risk for Major Bleeding
The VTE-BLEED risk score identified patients with pulmonary embolism at risk for in-hospital major
bleeding.
Direct-Acting Oral Anticoagulant Treatment for Acute Venous Thromboembolism
Although clinical trials are ongoing, the safety profile and net clinical benefit of DOACs for acute venous thromboembolism treatment are unclear.
No Association Found Between Locations of Venous Thromboembolism and Occult Cancer
An analysis of 2300 patients found similar prevalence of abdominal, pelvic, and thoracic cancer in patients with deep vein thrombosis and pulmonary embolism.
Better Guidelines for Diagnosing Pulmonary Embolism During Pregnancy Needed
Current guidelines to diagnosis pulmonary embolism in pregnant patients offer conflicting recommendations.
YEARS Criteria in Pulmonary Embolism Evaluation May Reduce Need for Imaging
D-dimer test adjustment based on pretest probability results may be a safe option to reduce the need for imaging during evaluation for pulmonary embolism.
Copeptin May Serve as Prognostic Biomarker for Pulmonary Embolism
Copeptin may be useful for identifying normotensive patients with pulmonary embolism who have a higher risk for an adverse outcome.
Varicose Veins May Increase Risk for Pulmonary Embolism
Varicose veins may increase the risk for pulmonary embolism and peripheral artery disease.
Pulmonary Embolism With Low Mortality Risk May Be Managed in Outpatient Setting
Observation in the emergency department followed by outpatient management with anticoagulation may be appropriate treatment for some patients with low-risk pulmonary embolism.
Next post in Thrombotic Disorders
